Bio-Rad Laboratories BIO
NYSE BIO
$376.69 +12.43 (+3.41%)
At close: Aug 20, 2026 · 1:24 PM UTC

Bio-Rad Laboratories (BIO) Gross Profit Growth (1y) (2010 - 2026)

Bio-Rad Laboratories (BIO) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 15.59%
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 17.10%
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 10.88%
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 12.38%
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 13.54%
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 20.50%
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 9.82%
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 4.20%
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 8.95%
10 Bio-Rad Laboratories 10.07 Bn 8.45 Bn 345.80 Mn 0.14%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.14%
Mar 31, 2026 1.11%
Dec 31, 2025 0.94%
Sep 30, 2025 -3.51%
Jun 30, 2025 -2.76%
Mar 31, 2025 -6.11%
Dec 31, 2024 -6.63%
Sep 30, 2024 6.02%
Jun 30, 2024 -2.04%
Mar 31, 2024 -10.07%
Dec 31, 2023 -7.76%
Sep 30, 2023 -9.90%
Jun 30, 2023 -8.23%
Mar 31, 2023 -9.99%
Dec 31, 2022 -0.70%
Sep 30, 2022 -14.64%
Jun 30, 2022 -1.52%
Mar 31, 2022 0.52%
Dec 31, 2021 -13.08%
Sep 30, 2021 18.84%